LaserStock29 wrote: Oilminerdeluxe wrote: Having another indication starting up cannot be a bad thing, Who knows what will happen if we have a successful start to Phase II. That ORF-money must have been put to use by now. One would think partners would be willing to participate if bladder is going well. Nothing ever happens fast though.
Because you've stated fast doesn't mean that we have to sit back and say oh.. i have to check my patience level... guess i was expecting too much. hogwash.
June 28/2018 was the 4.5m granted.. 1.5 years ago......
We already had paid for preclinical data done before the ORF. We had 2 animal data on GBM, Lung and Colon with Petri Dish on Cervical and Head/Neck...
The ORF was imo to refine the light/drug dosimitry and strategize for each indication with GBM and LUNG being the highest degree of difficulty....... no question.. Cervical, Throat and Colon being the anatomically simpler.
GBM had an update in 2019.. with more animal tests or some advancement from the ORF if i recall.
but 1.5 years... absolutely zero excuse to be in 2020 without completing at least a couple 2/5 of the indications at phase 1 'ready state'.
The only indication that has 'special consideration' for 'time' and checking our patience is Brain for obvious reasons as Dr.Mandel alluded to in the AGM.. toxicity studies etc.. it's understandable.
But with all the data on Esophagus.. Colon, Cervical with Photofrin that exists...... Im sorry man.. it's not complicated..
IMHO.